Literature DB >> 17417740

Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs.

M Marziniak1, R Mössner, C Kienzler, P Riederer, K-P Lesch, C Sommer.   

Abstract

Migraine is regarded as a polygenic disease and serotonergic pathways appear to play a major role in its pathogenesis. In the present study, the role of the 5-HT1A and 5-HT1B receptors in migraine was evaluated. The human 5-HT1A receptor gene transcription is modulated by a functional C-1019G promoter polymorphism. The 5-HT1B receptor is the main effector of vasoconstriction in meningeal and cerebral arteries and its functional G861C promoter polymorphism was investigated. We report a positive association of the GG genotype of the 5-HT1A promoter polymorphism with avoidance of physical activity during a migraine attack in comparison to the CC genotype (p = 0.008). Moreover, a positive association of the CC genotype of the G861C polymorphism of the 5-HT1B receptor with the reported intensity of the headache attack on the visual analogue scale was observed (CC 8.3 +/- 1.5 vs. GG 6.9 +/- 1.8; p < 0.05). An association of either polymorphism with migraine with or without aura could not be found. For the first time, our results indicate a role of allelic variation of the 5-HT1A receptor in motion related discomfort in migraineurs and a role of the 5-HT1B receptor polymorphism in headache intensity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417740     DOI: 10.1007/s00702-007-0713-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain.

Authors:  Susana Aznar; Zhaoxia Qian; Reshma Shah; Birgitte Rahbek; Gitte M Knudsen
Journal:  Brain Res       Date:  2003-01-03       Impact factor: 3.252

2.  Characterization of the human 5-hydroxytryptamine1B receptor.

Authors:  H Jin; D Oksenberg; A Ashkenazi; S J Peroutka; A M Duncan; R Rozmahel; Y Yang; G Mengod; J M Palacios; B F O'Dowd
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

Review 3.  Physiological basis and pharmacology of motion sickness: an update.

Authors:  B J Yates; A D Miller; J B Lucot
Journal:  Brain Res Bull       Date:  1998-11-15       Impact factor: 4.077

4.  5-HT1B receptor polymorphism and clinical response to sumatriptan.

Authors:  A MaassenVanDenBrink; M N Vergouwe; R A Ophoff; P R Saxena; M D Ferrari; R R Frants
Journal:  Headache       Date:  1998-04       Impact factor: 5.887

Review 5.  Molecular genetics of migraine headaches: a review.

Authors:  P Montagna
Journal:  Cephalalgia       Date:  2000-02       Impact factor: 6.292

6.  Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2.

Authors:  Y Hasegawa; S Higuchi; S Matsushita; H Miyaoka
Journal:  J Neural Transm (Vienna)       Date:  2002-04       Impact factor: 3.575

7.  Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice.

Authors:  A R Ase; T A Reader; R Hen; M Riad; L Descarries
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

8.  Facial pain increases nausea and headache during motion sickness in migraine sufferers.

Authors:  Peter D Drummond; Anna Granston
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

9.  Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations.

Authors:  J Lappalainen; J C Long; M Eggert; N Ozaki; R W Robin; G L Brown; H Naukkarinen; M Virkkunen; M Linnoila; D Goldman
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia.

Authors:  Claudia Rothe; Lise Gutknecht; Christine Freitag; Ralf Tauber; Rainald Mössner; Petra Franke; Jrgen Fritze; Gerd Wagner; Gregor Peikert; Berit Wenda; Philipp Sand; Christian Jacob; Marcella Rietschel; Markus M Nöthen; Henk Garritsen; Rolf Fimmers; Jürgen Deckert; Klaus-Peter Lesch
Journal:  Int J Neuropsychopharmacol       Date:  2004-02-25       Impact factor: 5.176

View more
  3 in total

1.  Significant association between rare IPO11-HTR1A variants and attention deficit hyperactivity disorder in Caucasians.

Authors:  Lingjun Zuo; Laura Saba; Xiandong Lin; Yunlong Tan; Kesheng Wang; John H Krystal; Boris Tabakoff; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-16       Impact factor: 3.568

2.  Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.

Authors:  Martin Marziniak; Anna Laura Herzog; Andrea Herzog; Rainald Mössner; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2008-05-14       Impact factor: 3.575

3.  Functional gene variants of the serotonin-synthesizing enzyme tryptophan hydroxylase 2 in migraine.

Authors:  Martin Marziniak; Claudia Kienzler; Gregor Kuhlenbäumer; Claudia Sommer; Rainald Mössner
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.